Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

Madison R. Mack(Sanofi (United States)), Brian Kim(Allen Institute for Brain Science), Rebecca Chibnall(Washington University in St. Louis), Todd A. Fehniger(Washington University in St. Louis), Wayne M. Yokoyama(Washington University in St. Louis), Éric Vivier(Centre d’Immunologie de Marseille-Luminy), Marina Cella(Centre National de la Recherche Scientifique), Eugene Park(Washington University in St. Louis), Patrick L. Collins(Washington University in St. Louis), Fang Wang(Jiangsu Province Hospital), David Sheinbein(Washington University in St. Louis), Haixia Niu(Shanghai Jiao Tong University), Ting-Lin B. Yang(Washington University in St. Louis), Carrie Heffington(Barnes-Jewish Hospital), Friederike Kreisel(Saint Louis University), Julia A. Wagner(Washington University in St. Louis), Anna M. Trier(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Marco Colonna(Washington University in St. Louis), David J. Margolis(University of Pennsylvania), Amy Xu(Washington University in St. Louis), Nancy D. Bodet(Washington University in St. Louis), Eugene M. Oltz(Washington University in St. Louis), Melissa M. Berrien-Elliott, Matthew McCullen(Washington University in St. Louis), Jonathan R. Brestoff(Washington University in St. Louis), Paola Lovato(Leo Pharma (Denmark))

Science Translational Medicine

February 26, 2020

Cited by 108

Related Papers

|Nature Immunology|2008|3.8k

|New England Journal of Medicine|2014|1.4k

|Journal of the American Academy of Dermatology|2013|1.3k

|Journal of the American Academy of Dermatology|2014|1.2k

|Science|2007|1.1k